Produkt
KlappentextEngineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.
Zusammenfassung
Detailed background for antibody generation and production
Chapters on production of antibody in bacterial, fungal, mammalian, insects and transgenic animal and plants
Scientific and technical approaches to accelerating the development of robust upstream and downstream processes
Identify the limitations in developing processes for antibody production
Detailed background for antibody generation and production
Chapters on production of antibody in bacterial, fungal, mammalian, insects and transgenic animal and plants
Scientific and technical approaches to accelerating the development of robust upstream and downstream processes
Identify the limitations in developing processes for antibody production
Details
ISBN/GTIN978-94-007-1256-0
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2011
Erscheinungsdatum18.05.2011
ReiheCell Engineering
Seiten346 Seiten
SpracheEnglisch
Gewicht707 g
IllustrationenX, 346 p.
Artikel-Nr.11452741
Rubriken
GenreMedizin